Table 3 30-day and 1-year clinical outcomes
| Â | ENTIRE COHORT | PROPENSITY MATCHED COHORT | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
NVE (n = 315) | PVE (n = 103) | P value | NVE (n = 315) | PVE (n = 103) | P value | |||||
30-DAY OUTCOME | ||||||||||
 30-day mortality | 26 | (8.3%) | 22 | (21.4%) | < 0.001 | 4 | (5.1%) | 16 | (20.3%) | 0.004 |
 Myocardial infarction | 1 | (0.3%) | 1 | (1.0%) | 0.439 | 0 | (0%) | 1 | (1.3%) | 0.238 |
 New pacemaker * | 23 | (7.3%) | 20 | (19.4%) | < 0.001 | 8 | (10.1%) | 11 | (13.9%) | 0.463 |
 New postoperative cerebrovascular events | 15 | (4.8%) | 8 | (7.8%) | 0.252 | 6 | (7.6%) | 4 | (5.1%) | 0.499 |
Stroke | 14 | (4.4%) | 5 | (4.9%) | 0.862 | 6 | (7.6%) | 3 | (3.8%) | 0.294 |
Intracranial bleeding | 1 | (0.3%) | 3 | (2.9%) | 0.077 | 0 | (0%) | 1 | (1.3%) | 0.238 |
 Postoperative AKI | 107 | (34.0%) | 47 | (45.6%) | 0.035 | 33 | (41.8%) | 32 | (40.5%) | 0.872 |
 Re-exploration for bleeding | 45 | (14.3%) | 26 | (25.2%) | 0.009 | 10 | (12.7%) | 17 | (21.5%) | 0.129 |
 Tracheostomy | 38 | (12.1%) | 21 | (20.4%) | 0.036 | 10 | (12.7%) | 15 | (19.0%) | 0.276 |
 Time of ventilation (h) | 18.2 | [11–68] | 32.8 | [17–120] | < 0.001 | 16.8 | [12–46] | 28.3 | [15–113] | 0.017 |
 ICU stay (d) | 4.0 | [2.0–8.0] | 5.0 | [3.0–13.0] | 0.009 | 3.0 | [1.0–6.0] | 5.0 | [2.0–12.0] | 0.042 |
 Hospital stay (d) | 12.0 | [8.0–16.0] | 14.5 | [10.0–20.0] | 0.007 | 12.0 | [7.0–17.0] | 15.0 | [11.0–20.0] | 0.015 |
1-YEAR OUTCOME | ||||||||||
 1-year mortality | 53 | (16.8%) | 34 | (33.0%) | < 0.001 | 11 | (13.9%) | 23 | (29.1%) | 0.020 |
 Re-admission to hospital | 94 | (29.8%) | 33 | (32.0%) | 0.478 | 31 | (39.2%) | 23 | (29.1%) | 0.835 |
 Relapse of endocarditis | 10 | (3.2%) | 3 | (2.9%) | 0.938 | 3 | (3.8%) | 2 | (2.5%) | 1.000 |
 New pacemaker* | 5 | (1.6%) | 4 | (3.9%) | 0.177 | 2 | (2.5%) | 1 | (1.3%) | 0.792 |
 AKI during follow-up | 23 | (7.3%) | 13 | (12.6%) | 0.071 | 11 | (13.9%) | 8 | (10.1%) | 0.883 |